ABCA9: A drug target and potential biomarker for the treatment of cancer

Target Name: ABCA9

NCBI ID: G10350

ABCA9

ABCA9: A drug target and potential biomarker for the treatment of cancer

ABCA9 (short for angiogenesis-associated cell adhesion molecule 9) is a protein that is expressed in various tissues of the body, including the blood vessels, lungs, heart, and kidneys. Its primary function is to promote the formation and maintenance of blood vessels, which are vital for the delivery of oxygen and nutrients to tissues and the removal of waste products.ABCA9 has also been shown to play a crucial role in the development and progression of various diseases, including cancer.

The search for new drug targets and biomarkers has become a major focus of research in the pharmaceutical industry in recent years.ABCA9 is a potential drug target due to its involvement in the regulation of blood vessel formation and its role in the development of various diseases.In this article, we will explore the biology of ABCA9 and its potential as a drug target and biomarker.

Biochemistry and function

ABCA9 is a member of the carcinoembryonic antigen (CEA) family, which includes proteins that are expressed in various tissues of the body, including the skin, lung, heart, and kidneys.These proteins are known as cancer antigens and are often used as targets for cancer treatments.

ABCA9 is primarily expressed in the endothelial cells, which are the cells that line the blood vessels.These cells are responsible for maintaining the integrity of the blood vessels and are crucial for their proper function.ABCA9 helps to regulate the formation and maintenance of blood vessels by promoting the migration and proliferation of endothelial cells.

In addition to its role in blood vessel formation,ABCA9 has also been shown to play a crucial role in the regulation of angiogenesis, which is the process by which new blood vessels are formed in the body.Angiogenesis is a critical process for the development and maintenance of tissues, including organs and limbs.ABCA9 helps to regulate the formation of new blood vessels by promoting the migration and proliferation of blood vessels.

ABCA9 has also been shown to play a role in the regulation of tissue repair and regeneration.After injury or disease, the body's response is to repair damaged tissue and promote the growth of new cells.ABCA9 helps to regulate this process by promoting the migration and proliferation of stem cells and the formation of new blood vessels.

Disease association

ABCA9 has been associated with the development and progression of various diseases, including cancer.Studies have shown that ABCA9 is highly expressed in various types of cancer, including breast, lung, and ovarian cancer.ABCA9 has also been shown to promote the growth and survival of cancer cells.

In addition to its association with cancer,ABCA9 has also been associated with a number of other diseases, including cardiovascular disease and autoimmune disorders.These diseases are characterized by the inflammation and damage of tissues, and they can be treated with drugs that target ABCA9.

Potential as a drug target

The potential of ABCA9 as a drug target is based on its involvement in the regulation of blood vessel formation, angiogenesis, and tissue repair and regeneration.ABCA9 has been shown to be a potent inhibitor of angiogenesis, and this has led to its potential as a drug target.

ABCA9 can be targeted by small molecules, such as those that inhibit its activity as a signaling molecule.These small molecules can be administered to cancer cells to inhibit their growth and survival.Several studies have shown thatABCA9 inhibitors have the potential to be effective in treating various types of cancer.

In addition to its potential as a cancer drug,ABCA9 has also been shown to have potential as a biomarker for the diagnosis and monitoring of cancer.This is because its expression is often increased in cancer cells, and its levels can be used as a

Protein Name: ATP Binding Cassette Subfamily A Member 9

Functions: Transporter that may play a role in monocyte differentiation and lipid transport and homeostasis

The "ABCA9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ABCA9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets